Doctors Will Now Be Able To Detect Atherosclerosis In Its Early Stages
Published On:November 06, 2018
A research published in the Journal of Nature Communications from Washington CD, USA stated that doctors will now be able to detect atherosclerosis with the help of the early signs and by understanding how the cells in the blood vessels change and eventually this will prevent blocking of arteries. The muscles cells that are present in the blood vessels have several tasks to perform majorly pumping blood all over the body and patching up any injuries that harms the blood vessels and according to the research the shifting of blood vessel from one task to another may lead to atherosclerosis and blocking of blood flow. The research held recently made it easy for doctors to understand the process of task shifting of the cells and detect the disorder in the very initial stage. Atherosclerosis is also as an initial cause of many dangerous cardiovascular diseases like heart arrest and strokes. There are still no complete treatments invented for reversing the atherosclerosis disorder but also some lifestyle changes like healthy diets and regular exercise can decrease the risk. Dr. Helle Jorgensen the author of the study stated that these cells look very similar to each other but are can be different to each other while during the research she also noted that very few cells actually stood out other lost the ability to even perform their basic tasks and represented a gene known as Sca1 and is majorly known to blot stem cells. To understand the outcome of these new cells and the history of the birth of these cells, the team of the researchers used a new technology called lineage labeling. Having information of all the types of cells made it easier to understand the behaviors of the disease and the ways to avoid atherosclerotic plaques. The main aim of the research was to find a way to detect the early stages of atherosclerosis and make the treatment faster and efficient.
Are you looking for a Market Research Reports? Just contact our consultant.